Inhibition of Lnc-OC1 Induced Cell Apoptosis and Decreased Cell Viability by Releasing miR-34a and Inhibiting PD-L1 in Endometrial Carcinoma

Clinical impact of PD-L1 and PD-1 expression in squamous cell cancer of the vulva

(2019) Fabinshy Thangarajah et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

HDAC6 inhibition synergizes with anti-PD-L1 therapy in ARID1A-inactivated ovarian cancer.

(2019) Takeshi Fukumoto et al.   CANCER RESEARCH

lncRNA HOTAIR promotes endometrial carcinoma cells proliferation by binding to PTEN via activating PI3k/Akt signaling pathway

(2019) Xiao-Hui Zhang et al.   MOLECULAR AND CELLULAR BIOLOGY

PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells

(2019) Annukka Pasanen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

MiR‐34a inhibits the proliferation, migration, and invasion of oral squamous cell carcinoma by directly targeting SATB2

(2019) Xin Ge et al.   JOURNAL OF CELLULAR PHYSIOLOGY

MiR-34a, as a suppressor, enhance the susceptibility of gastric cancer cell to luteolin by directly targeting HK1

(2018) Yan Zhou et al.   GENE

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression

(2018) Heng Lin et al.   JOURNAL OF CLINICAL INVESTIGATION

A novel lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and migration by sponging miR-34a and miR-34c

(2018) Fangfang Tao et al.   Journal of Genetics and Genomics

Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas

(2018) Jia Xu et al.   PLoS One

Non-Coding RNAs in Endometrial Physiopathology

(2018) Alessandro La Ferlita et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Survivin expression modulates the sensitivity of A549 lung cancer cells resistance to vincristine

(2018) Chengwei Zhou et al.   Oncology Letters

Integrated genomic and molecular characterization of cervical cancer

(2017)   NATURE

miR-200c suppresses endometriosis by targeting MALAT1 in vitro and in vivo

(2017) Zongwen Liang et al.   Stem Cell Research & Therapy

The Molecular Biology of Endometrial Cancers and the Implications for Pathogenesis, Classification, and Targeted Therapies

(2017) Nisha Bansal et al.   Cancer Control

Long Non-Coding RNA BANCR Promotes Endometrial Cancer Cell Proliferation and Invasion by Regulating MMP2 and MMP1 via ERK/MAPK Signaling Pathway

(2016) Danni Wang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Long non-coding RNAs, ASAP1-IT1, FAM215A, and LINC00472, in epithelial ovarian cancer

(2016) Yuanyuan Fu et al.   GYNECOLOGIC ONCOLOGY

Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy

(2016) Shengpeng Wang et al.   JOURNAL OF CONTROLLED RELEASE

miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD

(2016) Mingxia Zhu et al.   Molecular Medicine Reports

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

(2015) Edward B. Garon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition

(2014) Aditya Parikh et al.   Nature Communications

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of Genetic Polymorphisms in Cell-Cycle Control Genes and Susceptibility to Endometrial Cancer Among Chinese Women

(2011) Hui Cai et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Wild-type p53 controls cell motility and invasion by dual regulation of MET expression

(2011) C.-I. Hwang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms

(2010) Laura J Tafe et al.   MODERN PATHOLOGY